FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Viatris Lyrica CR Recall

Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Dis…

Viatris · Morgantown, WV

Risk level
Class II
Reported by FDA
Oct 6, 2021
Recall ID
D-0851-2021
Check your lot numberHow we source this data

Summary

Viatris recalled Lyrica CR starting Aug 23, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0851-2021 on Oct 6, 2021. Reason: Failed Dissolution Specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications

Product description

Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division of Pfizer Inc., NY, NY 10017, NDC 0071-1029-01

Lot numbers, UPCs & expiration codes

Lot #: DN5396, EP9726, EK2417, Exp. Date August 2022

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0851-2021
Classification
Class II
Status
Terminated
Recall initiated
Aug 23, 2021
FDA report date
Oct 6, 2021
Quantity
9,515 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Viatris

Original FDA data

Every field from FDA enforcement report D-0851-2021, exactly as published.

Show all FDA fields
City
Morgantown
State
WV
Status
Terminated
Country
United States
Event ID
88542
Address
781 Chestnut Ridge Rd
Code information
Lot #: DN5396, EP9726, EK2417, Exp. Date August 2022
Postal code
26505-2730
Report date
Oct 6, 2021
Product type
Drugs
Recall number
D-0851-2021
Classification
Class II
Recalling firm
Viatris
Product quantity
9,515 bottles
Termination date
Sep 7, 2022
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division of Pfizer Inc., NY, NY 10017, NDC 0071-1029-01
Distribution pattern
Nationwide within the United States
Recall initiation date
Aug 23, 2021
Initial firm notification
Letter
Center classification date
Sep 24, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0851-2021, published Oct 6, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls